All-cause mortality due to conduction abnormalities in the United States: Sex, racial, and geographic variations from 1999 to 2022.

IF 5.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Alireza Ghajar, Kyaw M Khant, Maeve M Sargeant, Tharun Bandarupalli, Binu Philips, Fabrizio R Assis, John N Catanzaro, Rajasekhar Nekkanti, Samuel F Sears, Ghanshyam Shantha
{"title":"All-cause mortality due to conduction abnormalities in the United States: Sex, racial, and geographic variations from 1999 to 2022.","authors":"Alireza Ghajar, Kyaw M Khant, Maeve M Sargeant, Tharun Bandarupalli, Binu Philips, Fabrizio R Assis, John N Catanzaro, Rajasekhar Nekkanti, Samuel F Sears, Ghanshyam Shantha","doi":"10.1016/j.hrthm.2024.09.010","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mortality related to conduction abnormalities in the United States (US) population is not well documented. Population-based stratification approaches can improve public health policies and targeted strategies.</p><p><strong>Objective: </strong>The purpose of this study was to evaluate all-cause mortality related to conduction abnormalities in the US population METHODS: The Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research database was used to calculate the age-adjusted mortality rate (AAMR) per 100,000 individuals older than 35 years related to conduction abnormalities between 1999 and 2022.</p><p><strong>Results: </strong>A total of 207,861 deaths were attributed to conduction abnormalities throughout the study period ,with 56,186 of these deaths occurring between 2020 and 2022. All-cause mortality related to conduction abnormalities has increased during the past decade with an exponential growth in 2020-2021 (coronavirus disease 2019 era; annual percent change of 16.6% per year). Although the mortality rates decreased in 2022, they remained elevated compared to 2019-2020. Throughout the past 2 decades, males consistently exhibited higher mortality rates than females, with the rate in 2022 being 1.5 times higher (AAMR 11.4 vs 7.0 per 100,000). Non-Hispanic Black patients experienced a significantly higher mortality rate compared to non-Hispanic White individuals in the study period (AAMR 13.7 vs 8.6 per 100,000 in 2022). In the past 2 decades, mortality has been persistently higher in rural and small- to medium-sized metropolitan areas than in large metropolitan urban areas.</p><p><strong>Conclusion: </strong>Mortality rates related to conduction abnormalities have increased over the past decade, and persistent disparities have been observed. These data suggest that continued innovative outreach approaches and engagement with underrepresented populations remain essential.</p>","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":" ","pages":""},"PeriodicalIF":5.6000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart rhythm","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.hrthm.2024.09.010","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Mortality related to conduction abnormalities in the United States (US) population is not well documented. Population-based stratification approaches can improve public health policies and targeted strategies.

Objective: The purpose of this study was to evaluate all-cause mortality related to conduction abnormalities in the US population METHODS: The Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research database was used to calculate the age-adjusted mortality rate (AAMR) per 100,000 individuals older than 35 years related to conduction abnormalities between 1999 and 2022.

Results: A total of 207,861 deaths were attributed to conduction abnormalities throughout the study period ,with 56,186 of these deaths occurring between 2020 and 2022. All-cause mortality related to conduction abnormalities has increased during the past decade with an exponential growth in 2020-2021 (coronavirus disease 2019 era; annual percent change of 16.6% per year). Although the mortality rates decreased in 2022, they remained elevated compared to 2019-2020. Throughout the past 2 decades, males consistently exhibited higher mortality rates than females, with the rate in 2022 being 1.5 times higher (AAMR 11.4 vs 7.0 per 100,000). Non-Hispanic Black patients experienced a significantly higher mortality rate compared to non-Hispanic White individuals in the study period (AAMR 13.7 vs 8.6 per 100,000 in 2022). In the past 2 decades, mortality has been persistently higher in rural and small- to medium-sized metropolitan areas than in large metropolitan urban areas.

Conclusion: Mortality rates related to conduction abnormalities have increased over the past decade, and persistent disparities have been observed. These data suggest that continued innovative outreach approaches and engagement with underrepresented populations remain essential.

美国因传导异常导致的全因死亡率:1999 年至 2022 年期间的性别、种族和地域差异。
背景:美国人口中与传导异常有关的死亡率并无详细记录。基于人群的分层方法可以改善公共卫生政策和有针对性的策略:评估美国人口中与传导异常有关的全因死亡率 方法:利用美国疾病预防控制中心 WONDER 数据库,计算 1999 年至 2022 年间每 10 万名 35 岁以上人口中与传导异常有关的年龄调整死亡率 (AAMR):在整个研究期间,共有 207,861 例死亡归因于传导异常,其中 56,186 例发生在 2020 年至 2022 年期间。在过去十年中,与传导异常有关的全因死亡率呈上升趋势,在2020-2021年间呈指数增长(COVID-19时代;年百分比变化(APC)为每年16.6%)。虽然 2022 年的死亡率有所下降,但与 2019-2020 年相比,死亡率仍然较高。在过去二十年中,男性死亡率一直高于女性,2022 年的男性死亡率是女性的 1.5 倍(AAMR 11.4 vs 7.0 per 100,000)。在研究期间,非西班牙裔黑人患者的死亡率明显高于非西班牙裔白人患者(2022 年的美国急性呼吸系统综合症死亡率为每十万人 13.7 例与每十万人 8.6 例)。在过去二十年中,农村和中小型城市地区的死亡率一直高于大型城市地区:结论:在过去十年中,与传导异常相关的死亡率有所上升,并且持续存在差异。这些数据表明,持续创新的外展方法和与代表性不足人群的接触仍然至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Heart rhythm
Heart rhythm 医学-心血管系统
CiteScore
10.50
自引率
5.50%
发文量
1465
审稿时长
24 days
期刊介绍: HeartRhythm, the official Journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society, is a unique journal for fundamental discovery and clinical applicability. HeartRhythm integrates the entire cardiac electrophysiology (EP) community from basic and clinical academic researchers, private practitioners, engineers, allied professionals, industry, and trainees, all of whom are vital and interdependent members of our EP community. The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education, and optimal health care policies and standards.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信